Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 43% ± 17% | |
neuron | 9 studies | 54% ± 25% | |
oligodendrocyte precursor cell | 9 studies | 33% ± 17% | |
GABAergic neuron | 7 studies | 37% ± 15% | |
interneuron | 7 studies | 46% ± 19% | |
amacrine cell | 6 studies | 59% ± 26% | |
retinal ganglion cell | 6 studies | 68% ± 33% | |
astrocyte | 6 studies | 44% ± 24% | |
enteroendocrine cell | 5 studies | 34% ± 22% | |
ON-bipolar cell | 5 studies | 49% ± 31% | |
Mueller cell | 5 studies | 42% ± 18% | |
pancreatic A cell | 4 studies | 91% ± 9% | |
type B pancreatic cell | 4 studies | 88% ± 9% | |
retinal bipolar neuron | 4 studies | 59% ± 31% | |
OFF-bipolar cell | 4 studies | 54% ± 30% | |
GABAergic amacrine cell | 4 studies | 50% ± 23% | |
retina horizontal cell | 4 studies | 66% ± 17% | |
pancreatic D cell | 3 studies | 95% ± 6% | |
epithelial cell | 3 studies | 27% ± 9% | |
glycinergic amacrine cell | 3 studies | 42% ± 13% | |
neuroendocrine cell | 3 studies | 65% ± 5% | |
retinal cone cell | 3 studies | 49% ± 17% | |
retinal rod cell | 3 studies | 36% ± 10% | |
rod bipolar cell | 3 studies | 70% ± 19% | |
abnormal cell | 3 studies | 40% ± 19% | |
hematopoietic stem cell | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 11051.56 | 2631 / 2642 | 98% | 668.80 | 692 / 705 |
adrenal gland | 19% | 433.59 | 48 / 258 | 91% | 978.62 | 209 / 230 |
pancreas | 56% | 923.76 | 185 / 328 | 44% | 97.88 | 79 / 178 |
thymus | 35% | 519.12 | 229 / 653 | 32% | 33.63 | 196 / 605 |
ovary | 25% | 326.53 | 45 / 180 | 23% | 29.01 | 98 / 430 |
skin | 24% | 795.42 | 440 / 1809 | 10% | 21.99 | 45 / 472 |
uterus | 6% | 80.39 | 11 / 170 | 14% | 25.13 | 66 / 459 |
breast | 1% | 7.25 | 3 / 459 | 17% | 62.98 | 188 / 1118 |
eye | 0% | 0 | 0 / 0 | 16% | 18.17 | 13 / 80 |
kidney | 1% | 12.28 | 1 / 89 | 13% | 11.74 | 113 / 901 |
liver | 0% | 0 | 0 / 226 | 9% | 21.60 | 36 / 406 |
prostate | 2% | 43.31 | 6 / 245 | 5% | 4.51 | 25 / 502 |
lung | 0% | 0 | 0 / 578 | 7% | 11.48 | 83 / 1155 |
stomach | 1% | 14.02 | 4 / 359 | 6% | 13.00 | 16 / 286 |
heart | 6% | 72.34 | 52 / 861 | 0% | 0 | 0 / 0 |
intestine | 2% | 28.36 | 23 / 966 | 3% | 5.95 | 15 / 527 |
esophagus | 0% | 5.22 | 6 / 1445 | 4% | 5.12 | 7 / 183 |
lymph node | 0% | 0 | 0 / 0 | 3% | 2.33 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 22.79 | 1 / 45 |
bladder | 0% | 0 | 0 / 21 | 2% | 5.11 | 9 / 504 |
peripheral blood | 1% | 22.18 | 12 / 929 | 0% | 0 | 0 / 0 |
adipose | 0% | 1.08 | 1 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.78 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0030154 | Biological process | cell differentiation |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0007399 | Biological process | nervous system development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0140678 | Molecular function | molecular function inhibitor activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | BEX1 |
Protein name | Protein BEX1 (Brain-expressed X-linked protein 1) |
Synonyms | |
Description | FUNCTION: Signaling adapter molecule involved in p75NTR/NGFR signaling. Plays a role in cell cycle progression and neuronal differentiation. Inhibits neuronal differentiation in response to nerve growth factor (NGF). May act as a link between the cell cycle and neurotrophic factor signaling, possibly by functioning as an upstream modulator of receptor signaling, coordinating biological responses to external signals with internal cellular states (By similarity). In absence of reductive stress, acts as a pseudosubstrate for the CRL2(FEM1B) complex: associates with FEM1B via zinc, thereby preventing association between FEM1B and its substrates (By similarity). . |
Accessions | ENST00000372728.4 Q9HBH7 |